Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Improving Goals of Care Discussion in Advanced Cancer Patients

Improving Advanced Cancer Patient-Centered Care by Enabling Goals of Care Discussions

Outcome
Results posted; no analysis attached
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
15 March 2016
Ended
16 May 2018
Enrollment
265 participants
Sites
4
Primary outcomes
Number of Participants Who Perceived Increased Goals of Care Discussions; Number of Patients Perception of Improved Goals of Care Discussions
Sponsor type
Academic / other
Results posted
1 October 2019
Last update
1 October 2019

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Results

Primary endpoint
Results posted; no analysis attachedAs posted on ClinicalTrials.gov ↗, registry record of 1 October 2019
Primary outcome
Number of Participants Who Perceived Increased Goals of Care DiscussionsPatients - GoC Intervention: 43 of 153Patients - Usual Care: 34 of 110Values: ParticipantsTime frame: up to 6 monthsNo analysis posted for this outcome (outcome 1)
Primary outcome
Number of Patients Perception of Improved Goals of Care DiscussionsPatients - GoC Intervention: 70 of 153Patients - Usual Care: 65 of 110Values: ParticipantsTime frame: up to 6 monthsNo analysis posted for this outcome (outcome 2)
Participants
Patients - GoC Intervention: 155 started, 153 completedPatients - Usual Care: 110 started, 110 completedOncologists - GoC Intervention: 11 started, 11 completedOncologists - Usual Care: 11 started, 11 completed
Serious adverse events
Patients - GoC Intervention: 0 of 0Patients - Usual Care: 0 of 0Oncologists - GoC Intervention: 0 of 0Oncologists - Usual Care: 0 of 0Participants with at least one serious adverse event, of those at risk, as posted
1 secondary outcome
Communication Skills Training
Oncologists - GoC Intervention 3.7 (1.96), n=11; Oncologists - Usual Care 2.2 (1.08), n=11 [mean number of skills tested, Standard Deviation]

Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The goal of this study is to increase and improve Goals of Care discussions for advanced cancer patients by training medical oncologists to conduct these discussions. The investigators will evaluate the GoC discussion's effects on patient satisfaction, receipt of treatment in line with preferences, use of aggressive treatment, and oncologist communication skill.

Detailed description public domain (ClinicalTrials.gov)

Among advanced cancer patients, discussions about prognosis, goals of care (GoC) and end-of-life preferences improve quality of life of patients and reduce rates of hospital and ICU admission. Yet, few patients know their chemotherapy treatments will not cure their disease despite nearly all wishing to receive information- good \& bad. Currently, 37% of advanced cancer patients have GoC clarifying discussions and when they do, it is often in the last 2 months of life when symptoms are uncontrollable and oncologists have no other treatments to offer. These discussions do not usually happen with the patient's personal oncologist. Current efforts to teach oncologists such skills are impractical, requiring a lot of time away from their office practice and do not take into account job pressures. The goal of this study is to increase and improve GoC discussions for advanced cancer patients by training medical oncologists to conduct these discussions and evaluate its effects on patient satisfaction, receipt of care in line with preferences, aggressive care utilization, and oncologist communication skill. The investigators will recruit 280 patients of which half will come from intervention doctors and the other from the control doctors. The investigators will train randomly selected oncologists to conduct GoC discussion. Patients will be surveyed at baseline within days of their GOC visit and at 6 months. Oncologists will be audio-taped at baseline and after training is complete to assess practice and skill to conduct GoC discussions. Primary outcomes include patient reported conduct of and satisfaction with GoC discussion. Secondary outcomes include oncologist communication skills, feasibility of performing GoC in the outpatient setting, receipt of care in line with preferences, use of hospice, chemotherapy or ICU in the last 30 days of life.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Number of Participants Who Perceived Increased Goals of Care Discussions [up to 6 months]. Count Of Participants, Participants. Patients - GoC Intervention (n=153): 43; Patients - Usual Care (n=110): 34.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Number of Patients Perception of Improved Goals of Care Discussions [up to 6 months]. Count Of Participants, Participants. Patients - GoC Intervention (n=153): 70; Patients - Usual Care (n=110): 65.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Communication Skills Training [up to 6 months]. Mean, number of skills tested (Standard Deviation). Oncologists - GoC Intervention (n=11): 3.7 (1.96); Oncologists - Usual Care (n=11): 2.2 (1.08).